Kwangdong Healthbio Co Ltd

Kwangdong Healthbio's capital structure is characterized by a debt-to-equity ratio of 1.55, indicating a moderate reliance on debt financing. The company holds KRW 9,940,308,520 in cash and equivalents, but this is offset by long-term debt of KRW 28,418,978,670, resulting in a net cash position that is negative after subtracting total debt. The current ratio of 0.82 suggests potential short-term liquidity constraints, as current liabilities exceed current assets. Profitability metrics show a return on equity (ROE) of -3.5% and a return on assets (ROA) of -1.03%, both significantly below the industry median for Food Processing. The company reported a net loss of KRW 640,823,180, despite generating KRW 5,117,201,190 in gross profit, indicating high operating expenses or non-operating losses. The company's revenue is concentrated in functional food and cosmetic products, with no disclosed geographic diversification beyond Korea. This lack of geographic segmentation increases exposure to local economic and regulatory risks. Growth trajectory is mixed. Revenue for the latest period was KRW 66,979,543,440, but the outlook for the current fiscal year is uncertain due to the net loss and negative ROE. The company's operating cash flow of KRW 3,353,284,640 and free cash flow of KRW 993,772,430 suggest some capacity to fund operations, but capital expenditures of KRW 1,273,789,500 indicate ongoing investment in infrastructure. Risk factors include medium liquidity risk due to the current ratio and negative net cash position. The company has a low dilution risk, with no near-term pressure for equity issuance. However, the net loss and high debt-to-equity ratio could pressure credit quality if operating performance does not improve. Recent filings and transcripts have not disclosed material events that would significantly alter the company's risk profile. The 10-K Risk Factors section highlights exposure to raw material price volatility and regulatory changes in the functional food and cosmetic sectors.